![](https://d3ilqtpdwi981i.cloudfront.net/aESKBeZ7sArbz-ggerZ5D10hBtU=/0x5:153x203/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/a6/00/60/a6006054-02a7-41c8-98f0-8500639c7461/10597.jpg)
Methadone and buprenorphine/naloxone are medication assisted treatment (MAT) options for treating opioid use disorder, yet attitudes regarding their use within abstinence-based recovery homes have not been assessed. The present investigation examined attitudes regarding MAT utilization among residents living in Oxford Houses. This cross-sectional investigation compared residents (n = 87) receiving MAT whose recent drug use involved opioids, and two groups not receiving MATs; those who had used opioids and those who had used substances other than opioids. The vast majority of residents were not receiving MAT, yet 32% reported MAT histories. Negative attitudes regarding MAT were observed among residents who were not receiving MAT. Those presently receiving MAT reported mixed attitudes regarding the use of methadone and buprenorphine/naloxone, and two of these residents reported they had never been prescribed MAT. Findings suggest that abstinence-based recovery homes such as Oxford Houses may not be optimal resources for persons receiving MATs. © 2018 Springer Science+Business Media, LLC, part of Springer Nature
Available at: http://works.bepress.com/christopher-beasley/20/